Position in OGI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$37,092
-$79,447 QoQ
Shares Held
36,365
-58.2% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 69 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. OGI ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in OGI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,092 | 36,365 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $116,539 | 86,970 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,457,935 | 867,819 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $906,784 | 446,692 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||